Management of Hepatolithiasis: Review of the Literature

• Published in: Current gastroenterology reports 2020-06, Vol.22 (6), p.30-30, Article 30
• Main Authors: Lorio, Eric, Patel, Pavan, Rosenkranz, Laura, Patel, Sandeep, Sayana, Hari
• Format: Article
• Language: English
• Subjects: Bacteria; Bacterial infections; Bile ducts; Cholangitis; Cholesterol; Disease; Endoscopy; Fatty acids; Gallbladder; Gallbladder diseases; Gallstones; Gastroenterology; Growth factors; Hyperplasia; Inflammation; Kinases; Medicine; Medicine & Public Health; Metabolism; Pancreas and Biliary Tract (O Haluszka and H Gavini; Parasites; Pathogenesis; Proteins; Section Editors; Topical Collection on Pancreas and Biliary Tract
• ISSN: 1522-8037; 1534-312X
• DOI: 10.1007/s11894-020-00765-3

Purpose of Review Hepatolithiasis is a disease characterized by intrahepatic stone formation. In this article, we review the features of this disease and explore the established and emerging treatment modalities. Recent Findings Recent reports show an increasing prevalence of hepatolithiasis, likely owed to increased immigration and shifts in the Western diet. New pharmacotherapy options are limited and are often only supportive. Endoscopic intervention still cruxes on removal of impacted stones, though new techniques such as bile duct exploratory lithotomy and lithotripsy continue to advance management. Although hepatectomy of the effected portion of the liver offers definitive therapy, alternative less invasive modalities such as combined endoscopic/interventional radiology modalities have been utilized in select patients. Additionally, liver transplant serves as an option for otherwise incurable hepatolithiasis with coexisting liver dysfunction. Summary Multiple emerging pharmacologic and procedural interventions may provide novel treatment for hepatolithiasis. While definitive therapy remains resection of affected liver segments, these modalities offer hope for less invasive approaches in the future.